Literature DB >> 26681238

Conceptualizing a subtype of patients with chronic pain: The necessity of obtaining a history of sexual abuse.

David R Spiegel1, Ayesha M Shaukat2, Aidan L Mccroskey2, Aparna Chatterjee2, Tamana Ahmadi2, Drew Simmelink2, Edward C Oldfield2, Christopher R Pryor2, Michael Faschan2, Olivia Raulli2.   

Abstract

Lifetime history of sexual abuse is estimated to range between 15% and 25% in the general female population. Cross-sectional studies have shown that sexual assault survivors frequently report chronic musculoskeletal pain and functional somatic syndromes. Treating chronic pain with opioids went from being largely discouraged to being included in standards of care and titrating doses until patients self-report adequate control has become common practice, with 8% to 30% of patients with chronic noncancer pain receiving opioids. In this clinical review, we will discuss the association between survivors of sexual assault and chronic pain/functional somatic syndromes. We will further review evidence-based treatment strategies for this "pain-prone phenotype."
© The Author(s) 2015.

Entities:  

Keywords:  Centralized Pain Syndromes; Childhood sexual abuse; and Opiate Misuse

Mesh:

Substances:

Year:  2016        PMID: 26681238     DOI: 10.1177/0091217415621268

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  3 in total

1.  Mechanisms of chronic pain - key considerations for appropriate physical therapy management.

Authors:  Carol A Courtney; César Fernández-de-Las-Peñas; Samantha Bond
Journal:  J Man Manip Ther       Date:  2017-03-21

Review 2.  Novel Therapies for Centralized Pain: a Brief Review.

Authors:  Jade I Basem; Paul Ryan Haffey
Journal:  Curr Pain Headache Rep       Date:  2022-09-28

3.  Suicidal ideation among adults with a recent sexual assault: Prescription opioid use and prior sexual assault.

Authors:  Amanda K Gilmore; Christine K Hahn; Anna E Jaffe; Kate Walsh; Angela D Moreland; Erin F Ward-Ciesielski
Journal:  Addict Behav       Date:  2018-05-31       Impact factor: 3.913

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.